Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis

20260 citationsJournal Articlegold Open Access

Authors

Anil Ananthaneni · Louisiana State University Health Sciences Center Shreveport

Maria Isabel Planek · University of Chicago

Alan Kogan · Illinois Tool Works (United States)

Abstract

Multimodality imaging is essential to differentiate primary obstructive HCM from HH-related cardiomyopathy. In this case, mavacamten was a well-tolerated alternative, though further data are needed to establish broader applicability.

Topics & Keywords

Iron Metabolism and Disorders Hemoglobinopathies and Related Disorders Complement system in diseases

Publication Details

Published in: JACC Case Reports

DOI: 10.1016/j.jaccas.2026.107736

Field-Weighted Citation Impact: 0.00

Command Palette

Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis

Authors

Abstract

Topics & Keywords

Publication Details